Trial intelligence / Profile preview

BASH-PC: BAE for Men Starting Hormones for Prostate Cancer

NCT04331717Phase 2Withdrawn

Sponsor
Sidney Kimmel Comprehensive Cancer Center
Start
Nov 2020
Primary completion
Aug 2023
Countries
1
01

Overview

Phase 2, open-label, single-arm trial in obesity, sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Number of participants who experience at least 5 percent weight loss at 6 months. Planned start Nov 2020; status: withdrawn.

02

Conditions

obesity

Beyond the preview

Go deeper on NCT04331717.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04331717.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call